The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Immunosuppressive Management After Heart Transplantation

Multi-layered immunosuppression in heart transplant recipients to prevent rejection and support long-term survival.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kardiyoloji department. Book Appointment →

What is Immunosuppressive Management After Heart Transplantation?

Heart transplantation is the gold standard for end-stage heart failure. Success relies on long-term immunosuppressive therapy. The standard regimen typically combines a calcineurin inhibitor (tacrolimus or cyclosporine), an antimetabolite (mycophenolate mofetil) and a tapering dose of corticosteroids.

Induction therapy may use polyclonal anti-thymocyte globulin or basiliximab. In advanced care, mTOR inhibitors (sirolimus, everolimus) may offer benefit in cardiac allograft vasculopathy.

Immunosuppressive side effects include nephrotoxicity, diabetes, hypertension, infections, malignancy and bone marrow suppression. Regular biopsy and hemodynamic monitoring are standard.

Symptoms

Fever and signs of infection
Dyspnea and edema
Changes in blood pressure or glucose
Renal dysfunction
Tremor and headache
Diarrhea and nausea
Skin lesions

Risk Factors

Donor-recipient mismatch
Prior sensitization (panel reactive antibody)
Poor medication adherence
Intense infection exposure
Diabetes, chronic kidney disease
Steroid dependence
Comorbidities such as malignancy

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Fever and fatigue
  • New dyspnea
  • Diarrhea and dehydration
  • Severe headache or altered consciousness
  • Decreased urine output
  • Focal signs of infection

Treatment Methods

01
Induction (ATG or basiliximab)
02
Maintenance (calcineurin inhibitor + MMF + steroid)
03
Transition to mTOR inhibitor
04
Infection prophylaxis (valganciclovir, TMP-SMX)
05
Routine endomyocardial biopsy
06
Cardiac allograft vasculopathy screening
07
Multidisciplinary transplant team

Which Department to Visit?

You can visit our Kardiyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kardiyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Hypertension (High Blood Pressure)

Kardiyoloji

Hypertension is a condition in which blood pressure readings remain above 140/90 mmHg; early treatment helps prevent serious complications.

Coronary Artery Disease

Kardiyoloji

Narrowing of the coronary arteries due to atherosclerosis can cause chest pain (angina) and heart attack.

Heart Failure

Kardiyoloji

Heart failure is a chronic cardiac condition characterized by shortness of breath, leg swelling, and fatigue.

Heart Attack (Myocardial Infarction)

Kardiyoloji

A heart attack is a medical emergency; because heart muscle is lost by the minute, immediate intervention saves lives.

Atrial Fibrillation

Kardiyoloji

Atrial fibrillation is a common arrhythmia characterized by an irregular heartbeat and increased risk of stroke.

Heart Palpitations

Kardiyoloji

Palpitations are usually due to benign causes, but underlying cardiac rhythm disorders must be ruled out.

Heart Valve Diseases

Kardiyoloji

Valve stenosis or regurgitation increases the workload of the heart and, over time, can lead to heart failure.

Aortic Aneurysm

Kardiyoloji

Aortic aneurysms are often silent; early diagnosis allows treatment before rupture (a life-threatening tear).

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.